AI prequalified leads & due diligence

Find promising startups
before your competitors do.

AI-Powered systematic due diligence on every Medical Device, diagnostic, and life science startup with odds of commercial success, trusted market models and contact info, all in one BD workflow.

›
Early Discovery
Find high-potential startups before big investors do
›
Systematic Due Diligence
Same 8-dimension framework on every lead, every time
›
Trusted Market Models
Verified market models, proprietary model, not LLM guesses
›
BD Workflow Ready
LinkedIn profiles included, Sales Navigator in one click
Start free trial → See a sample report

No credit card required  ·  10-day free trial  ·  Cancel anytime

ScopeMedTech Find Opportunity interface
Instant
Full 8-page analysis generated
8
Commercial dimensions assessed
Verified
Market data, proprietary model
10×
Lower cost than a consultant
What ScopeMedTech does
Two capabilities.
No competitor offers both.

PitchBook has the data. LLM models give unverified answers. Neither tells you whether a Medical Device startup is actually worth pursuing, or what the verified market opportunity looks like.

Capability 01, Find
Discover early-stage MedTech companies before the market does

ScopeMedTech continuously scans funding announcements, new domain registrations, clinical trial filings, and conference data, surfacing promising Medical Device and diagnostic startups at the earliest stage, before big competitors and investors do.

  • ✓
    Search by device type, indication, stage, and location
  • ✓
    Companies ranked by odds of commercial success
  • ✓
    Automated clinical segment identifier, precise categorisation
  • ✓
    LinkedIn profiles included, one click to Sales Navigator
Find MedTech leads
Capability 02, Assess
Systematic due diligence. Trusted market models. Instantly.

Every Medical Device, diagnostic, and life science company gets the same structured AI assessment. The result: a verified odds of commercial success score and automated market sizing, based on a proprietary model, not LLM-generated guesses.

  • ✓
    Odds of commercial success, scored Low / Good / Excellent
  • ✓
    Verified market models, proprietary clinical segment model
  • ✓
    8 dimensions: clinical need, competition, team, technical, patent, financing, regulatory, reimbursement
  • ✓
    Structured output trusted as LLM context, export PDF or HTML
See a sample report
Apreo Health: Analysis (Summary View)
SCOPE MEDTECH
Assessment Output
Team:
★★★★★
Multiple successful entrepreneurs
Clinical Need:
★★★★★
Very Strong
Competition:
★★★★★
First Mover
Technical:
★★★★★
Moderate
Patent:
★★★★★
Good patent portfolio
Financing:
★★★★★
Well-funded to reach milestones
Regulatory:
★★★★★
Running pivotal trial
Reimbursement:
★★★★★
No Code / Unlisted
Opportunity Rollup
Odds of Success:
70%
Low
Good
Excellent
0%50%70%100%
Market Segment:
Anesthetic and Respiratory
Respiratory Device Accessories
$346M – $380M
Verified market models · Proprietary model
Potential Market Share Post-Launch
1.15%
Y1
3.45%
Y2
8.05%
Y3
16.10%
Y4
23.00%
Y5
Key Takeaway: Apreo Health's BREATHE Airway Scaffold offers a novel, minimally invasive solution for severe emphysema, addressing a significant unmet need in respiratory care.
1 of 8 · Generated by ScopeMedTech
apreohealth.com · LinkedIn →
Why teams switch
Every tool leaves a gap.
None of them form an opinion.

You have data. You have signals. But none of your current tools tell you whether a specific MedTech company is worth pursuing, or whether the market data you're seeing is verified.

PitchBook
Tells you who got funded, not whether the Medical Device technology is clinically sound, regulatory-ready, or reimbursable. Data without judgment.
ScopeMedTech adds
A structured opinion across all 8 commercial dimensions, plus verified market models from a proprietary clinical segment model.
LLM / AI Models
Generate plausible-sounding market data that is unverified and unstructured. No systematic due diligence framework, no reproducible output, no BD workflow integration.
ScopeMedTech replaces
Verified market models from a proprietary model. Structured, consistent output that can serve as trusted LLM context for your own AI workflows.
Consultants & spreadsheets
$5,000–$15,000 per engagement. Two-week turnaround. Different analysts apply different criteria, no consistency across your pipeline.
ScopeMedTech replaces
The same rigorous 8-dimension assessment on every diagnostic and life science lead, consistently, instantly, at a fraction of the cost.
Signal tools
Tells you when a MedTech company got funded or filed a trial. Says nothing about whether it's clinically viable or commercially sound.
ScopeMedTech adds
The judgment layer. Integrates seamlessly into your BD workflow, from discovery to qualified lead to Sales Navigator outreach in one platform.
How it works
From discovery to BD outreach, in one workflow
1
Find New
Describe your thesis, device type, indication, stage, location, or enter a company name
2
Discover New
Early-stage MedTech companies surface automatically, ranked by odds of commercial success
3
Assess
Systematic AI due diligence across 8 dimensions, with verified market models, instantly
4
Connect New
LinkedIn company profiles link directly to Sales Navigator, book the meeting in one click
5
Close
Share reports with your team, track milestones, your full BD pipeline in one place
What customers say
Used by MedTech BD, investment,
and strategy teams
★★★★★

"ScopeMedTech is a concise evaluation of a company and its viability in a market. Great screening tool for gauging appropriate engagement for investors, CDMOs, and strategic partners."

Mike Brenzel
CTO · Nextern Innovation
★★★★★

"A consistent, structured framework for assessing new device ideas, enabling faster, more confident decision-making. Saves time and helps teams prioritize the most promising opportunities."

Benjamin Austin
Director of BD · Philips Medisize
★★★★★

"Huge for backing up gut feelings with real, quantifiable metrics that actually mean something. Handles the heavy lifting of multidisciplinary analysis, using AI."

Frank Jaskulke
VP of Sales and BD · Avio MedTech
Pricing
High value. Simple pricing.

10-day free trial · No credit card required

Save 20% with annual billing

Pro
$99/mo
billed annually
$129/mo if billed monthly
  • Unlimited analyses, instantly
  • Full lead sourcing & discovery
  • Odds of commercial success scoring
  • Verified automated market sizing
  • LinkedIn profiles for Sales Navigator
  • Clinical segment identifier
  • PDF & HTML export
  • Priority support · 1 user seat
Start free trial →

For individual investors, BD professionals, and MedTech consultants.

Team
$249/mo
billed annually
$319/mo if billed monthly
  • Everything in Pro
  • 3 user seats
  • Shared workspace & watchlists
  • Strategic fit scoring for CDMOs
  • CDMO-specific templates
  • Store, share & track reports
  • Dedicated support
Start free trial →

For CDMO, CRO, and BD teams of 2–5 professionals.

Enterprise
On Request
Custom pricing · Annual contract
  • API access & automation
  • Unlimited seats & reports
  • Shared workspace
  • Custom integrations & BD workflow
  • Private datasets & models
  • Dedicated account manager
  • Customizable output formats

For organizations requiring API, custom models, and enterprise BD workflows.

vs. the alternatives
Systematic due diligence and verified market models.
No other tool delivers both.
Capability PitchBook LSI Zapyrus LLM Models ScopeMedTech
Odds of commercial success✗ None✗ None✗ None✗ None✓ Scored & calibrated
Automated clinical segment identifier✗ None~ Manual✗ None~ Generic / unstructured✓ Proprietary automated
Verified market models~ Financial data only✓ Segment forecasts✗ None✗ Unverified LLM output✓ Proprietary model
8-dimension AI due diligence✗ None~ Basic profile✗ None~ Unstructured, inconsistent✓ Full report, instantly
LLM-trusted structured context✗ No✗ No✗ No✗ Circular✓ Structured output
Proactive MedTech lead discovery~ Funding alerts~ Hot 25 list✓ Sales triggers✗ No✓ Full sourcing feed
BD workflow integration✗ No✗ No✓ CRM triggers✗ No✓ End-to-end
LinkedIn profiles for outreach✗ No✗ No~ Add-on✗ No✓ Built in
FAQ
Common questions
How is ScopeMedTech different from PitchBook or LLM models?
PitchBook tracks financial events, not whether a Medical Device company is commercially viable. LLM models generate unverified market models without a systematic framework. ScopeMedTech delivers verified market models from a proprietary clinical segment model and a structured 8-dimension due diligence assessment, consistently, on every lead.
What does "Odds of Commercial Success" mean?
A composite score across all 8 dimensions, clinical need, competition, team, technical challenge, patent, financing, regulatory stage, and reimbursement, expressed as a percentage. Scores are calibrated: under 50% is Low, 50–70% is Good, above 70% is Excellent. Tracked over time so you can see momentum improving or declining.
How is the market data verified?
ScopeMedTech uses a proprietary clinical segment identification model, not general-purpose LLM output, to match each MedTech company to its precise device category and calculate addressable US market size, growth rate, and 5-year market share projections. This is why our data is verifiable, not just plausible.
How does lead sourcing work?
ScopeMedTech continuously monitors funding announcements, new domain registrations, clinical trial filings, and conference presentations to surface early-stage Medical Device, diagnostic, and life science companies. Results are ranked by odds of commercial success, with LinkedIn company profiles for direct outreach.
Can it integrate into our BD workflow?
Yes. Reports export as PDF and HTML instantly. The Team plan includes a shared workspace so your whole BD team works from the same platform, shared watchlists, CDMO-specific templates, and strategic fit scoring. The Enterprise plan includes API access for custom integrations into your existing CRM or BD workflow.
How fast is the analysis?
Instant for companies already in our database. New companies or product concepts take up to 30 seconds. Reports are available to export immediately. The 10-day free trial lets you run your real pipeline before committing to a plan.

Give us one company
you've recently evaluated.

We'll run the analysis live, odds of success, verified market models, 8-dimensional assessment, instantly.

Start free trial → See a sample report